Abstract:Human milk oligosaccharides (HMOs) are an unconjugated class of glycans that have been implicated for their role in promoting the healthy development of the brain-gut axes of infants. Production of HMOs is ever-changing and specifically tailored for each infant in response to various biological factors (e.g., cognitive development, diseases, or allergies). While every HMO consists of up to only five monosaccharides, their structures can be composed of many possible glycosidic linkage positions and corresponding α/β anomericities, linear or branched chains, and potential fucosylation/sialylation modifications, thus leading to a tremendous degree of isomeric heterogeneity. With limited availability of authentic standards for every putative HMO structure (estimated to be >200 total), new analytical methods are needed for their accurate characterization. Complete sequencing of the human milk glycome would enable a better understanding of their infant-specific biological roles and potentially lead to their widespread incorporation into infant formula. Herein, we explore the use of our high-resolution cyclic ion mobility spectrometry-mass spectrometry (cIMS-MS)-based platform for the separation of core disaccharide and trisaccharide isomer building blocks as a first step toward the sequencing of larger HMOs. By utilizing the flexible capabilities of the cIMS array, separation pathlengths were extended up to 40 m, thus enabling the resolution of all seven sets of sialylated, fucosylated galactosyllactose and lactosamine HMO building block isomers. Additionally, we assessed the utility of pre-/post-cIMS tandem mass spectrometry (MS/MS) and tandem cIMS (cIMS/cIMS) for the characterization of HMOs based on their diagnostic fragmentation patterns and mobility fingerprints. We anticipate that our presented cIMS-MS-based methodology will enable the better characterization of larger, unknown HMOs when incorporated into an overall workflow that also includes online liquid chromatography and enzymatic hydrolyses.

Isolation of Human Milk Difucosyl Nona- and Decasaccharides by Ultrahigh-Temperature Preparative PGC-HPLC and Identification of Novel Difucosylated Heptaose and Octaose Backbones by Negative-Ion ESI-MSn.

Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Analysis of Human Milk Neutral and Sialylated Free Oligosaccharides Using Girard's Reagent P On-Target Derivatization.

Toward Sequencing the Human Milk Glycome: High-Resolution Cyclic Ion Mobility Separations of Core Human Milk Oligosaccharide Building Blocks

Separation and Structural Sequence Analysis of Sialylated HMOs Via Tandem Mass Spectrometry

Structural Analysis of High Degree Polymerization Isomers of Human Milk Oligosaccharides Based on Electrospray Ionization-Quadrupole-Time of Flight Mass Spectrometry

Comparison of Different Labeling Techniques for the LC-MS Profiling of Human Milk Oligosaccharides

Determination of Human Milk Oligosaccharides by Porous Graphite Carbon Adsorption Coupled with High-Performance Liquid Chromatography-Mass Spectrometry

Biochemical Characterization of Helicobacter Pylori Α1–3-Fucosyltransferase and Its Application in the Synthesis of Fucosylated Human Milk Oligosaccharides

Improved Simple Sample Pretreatment Method for Quantitation of Major Human Milk Oligosaccharides Using Ultrahigh Pressure Liquid Chromatography with Fluorescence Detection.

Profiling of Human Milk Oligosaccharides for Lewis Epitopes and Secretor Status by Electrostatic Repulsion Hydrophilic Interaction Chromatography Coupled with Negative-Ion Electrospray Tandem Mass Spectrometry.

Microbial production of human milk oligosaccharide lactodifucotetraose

Development of High-Throughput UPLC-MS/MS Using Multiple Reaction Monitoring for Quantitation of Complex Human Milk Oligosaccharides and Application to Large Population Survey of Secretor Status and Lewis Blood Group.

Substrate specificity and transfucosylation activity of GH29 α-l-fucosidases for enzymatic production of human milk oligosaccharides

Chromatographic methods for the analysis of oligosaccharides in human milk

Isomer-specific Quantification of Human Milk Oligosaccharides Based on Girard Reagent P-d0/d5 Derivatization and Trapped Ion Mobility Spectrometry-Mass Spectrometry

High-titer de novo biosynthesis of the predominant human milk oligosaccharide 2' fucosyllactose from sucrose in Escherichia coli.

Innovative direct introduction‐ion mobility–mass spectrometry (DI‐IM‐MS) approach for fast and robust isomer‐specific quantification in a complex matrix: Application to 2′‐fucosyllactose (2'‐FL) in breast milk

Versatile Strategy for the Chemoenzymatic Synthesis of Branched Human Milk Oligosaccharides Containing the Lacto‐N‐biose Motif

Regioselective Enzymatic Galactosylation Enabled Divergent Synthesis of Asymmetrical Biantennary Human Milk Oligosaccharides

Profiling Of Sialylated Oligosaccharides In Mammalian Milk Using Online Solid Phase Extraction-Hydrophilic Interaction Chromatography Coupled With Negative-Ion Electrospray Mass Spectrometry

Enzymatic production of a suite of human milk oligosaccharides directly in milk